GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

MK0653, ezetimibe

Company
Organon and Co
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details
  • Completed NCT NCT00092560

    Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

    Not yet reported Organon and Co 587 participants Est. completion 2003-12
    Other conditions: Hypercholesterolemia, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00092573

    Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

    Not yet reported Organon and Co 576 participants Est. completion 2004-11
    Other conditions: Hypercholesterolemia, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00092586

    Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)

    Not yet reported Organon and Co 2904 participants Est. completion 2003-10
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00092599

    Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)

    Not yet reported Organon and Co 410 participants Est. completion 2004-07
    Other conditions: Hypercholesterolemia, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00092612

    Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)

    Not yet reported Organon and Co 372 participants Est. completion 2004-06
    Other conditions: Hypercholesterolemia, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00092625

    Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

    Not yet reported Organon and Co 442 participants Est. completion 2004-08
    Other conditions: Hypercholesterolemia, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00092638

    An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

    Not yet reported Organon and Co 450 participants Est. completion 2004-08
    Other conditions: Hypercholesterolemia, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00092716

    Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)

    Not yet reported Organon and Co 655 participants Est. completion 2003-04
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00092807

    Sitosterolemia Extension Study (0653-003)(COMPLETED)

    Not yet reported Organon and Co 37 participants Est. completion 2004-11-30
    Other conditions: Lipid Metabolism, Inborn Errors, Heart Disease
    View official trial listing →
  • Completed NCT NCT00092820

    Sitosterolemia Extension Study (0653-004)(COMPLETED)

    Not yet reported Organon and Co 58 participants Est. completion 2004-11-30
    Other conditions: Lipid Metabolism, Inborn Errors, Heart Disease
    View official trial listing →
  • Completed NCT NCT00092898

    An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)

    Not yet reported Organon and Co 30 participants Est. completion 2005-10
    Other conditions: Lipid Metabolism, Inborn Errors, Heart Disease
    View official trial listing →
  • Completed NCT NCT00157911

    A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)

    Not yet reported Organon and Co 136 participants Est. completion 2003-12
    Other conditions: Hypercholerolemia
    View official trial listing →
  • Completed NCT NCT00328523

    TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)

    Not yet reported Organon and Co 1496 participants Est. completion 2006-01
    Other conditions: Hypercholesterolaemia, Hyperlipidaemia
    View official trial listing →
  • Completed NCT NCT00395473

    Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)

    Not yet reported Organon and Co 141 participants Est. completion 2005-11
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00457275

    Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe (0653-070)

    Not yet reported Organon and Co 440 participants Est. completion 2005-11
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00551447

    A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)

    Not yet reported Organon and Co 616 participants Est. completion 2003-03
    Other conditions: Coronary Disease
    View official trial listing →
  • Completed NCT NCT00551876

    Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)

    Not yet reported Organon and Co 214 participants Est. completion 2003-01
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00652301

    A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)

    Not yet reported Organon and Co 40 participants Est. completion 2004-04
    Other conditions: Cholesterol
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.